Menu
Recruiting NCT06907771

Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer

Observational Ovarian Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Ovarian Cancer. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Ovarian cancer is the 8th leading cause of cancer-related death in women. Its prognosis is poor, with diagnosis often made at an advanced stage. Patient management has evolved in recent years with more radical surgeries and the introduction of maintenance treatment following neoadjuvant chemotherapy.

Primary outcome measures

  • Study of progression-free survival at 36 months [Time frame: At 36 months]

Eligibility criteria

Inclusion criteria

  • Adult patient (≥18 years old)
  • Operated on at the HUS between January 1, 2010 and December 31, 2022
  • Having undergone primary or interval cytoreductive surgery
  • Suffering from stage FIGO IIIC or IV high-grade serous carcinoma of ovarian origin

Exclusion criteria

  • Patiente ayant exprimé son opposition à la réutilisation de ses données à des fins de recherches scientifiques.
  • Autres types histologiques de cancer de l'ovaire
  • Stades de la maladie FIGO I, II, IIIA et IIIC
  • Chirurgie de clôture.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-only

Study locations

France · 1 center
  • Service de Gynécologique et d'Obstétrique - CHU de Strasbourg - France — Strasbourg

Identifiers

NCT: NCT06907771 · 9301

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗